Breath-Held MRI could replace painful liver biopsies
NCT ID NCT04429100
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new, fast MRI technique that measures collagen in the liver to detect scarring (fibrosis) without a needle biopsy. Researchers will compare the MRI results with standard tests in 200 adults with liver disease and healthy volunteers. The goal is to find a safer, more comfortable way to diagnose early-stage liver fibrosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Chinese University of Hong Kong, Prince of Wale Hospital
RECRUITINGHong Kong, Shatin, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can extra doses of an old drug reverse liver scarring?
- Can Weight-Loss surgery beat drugs for advanced liver damage?
- Navy beans take on fatty liver: a diet swap put to the test
- Could a cholesterol drug and a bile acid pill help reverse liver scarring?
- Stick-On ultrasound patch could spot liver damage without a specialist
- Food flavors on the breath may reveal hidden liver disease